Virtu Financial LLC

Position in CRDF — Cardiff Oncology, Inc.

CIK 1533964 New York, NY

Position in CRDF

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$92,726

+$70,688 QoQ

Shares Held

71,328

+424.3% QoQ

Ownership

0.092%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#31

of 104 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Virtu Financial LLC holds $37,834,089 across 147 Biotechnology names. CRDF ranks #66 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	58,459	$4,130,128
2	APGE	Apogee Therapeutics, Inc.	29,790	$3,954,026
3	ABVX	Abivax S.A.	19,155	$2,552,595
4	AXSM	Axsome Therapeutics, Inc.	9,220	$2,256,779
5	KYMR	Kymera Therapeutics, Inc.	12,556	$1,439,796
6	PTGX	Protagonist Therapeutics, Inc	8,163	$1,000,620
7	TGTX	Tg Therapeutics, Inc.	17,524	$962,768
8	IOVA	Iovance Biotherapeutics, Inc.	221,500	$921,440

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$92,726	71,328	+424.3%	Shares	Defined	2026-08-13
2026-03-31	$22,038	13,604	-64.6%	Shares	Defined	2026-05-14
2025-12-31	$108,125	38,479	+100.3%	Shares	Defined	2026-02-23
2025-03-31	$60,325	19,212	-62.5%	Shares	Defined	2025-05-12
2024-12-31	$222,125	51,181	+138.1%	Shares	Defined	2025-02-11
2023-12-31	$31,808	21,492	-45.4%	Shares	Defined	2024-02-26
2022-12-31	$55,101	39,358	+14.7%	Shares	Defined	2023-02-15
2022-09-30	$52,838	34,311	+173.1%	Shares	Defined	2022-11-07
2022-06-30	$27,638	12,563	-36.9%	Shares	Defined	2022-08-09
2021-06-30	$132,501	19,925	-40.1%	Shares	Defined	2021-09-17
2021-03-31	$307,941	33,255	+61.4%	Shares	Defined	2021-05-19
2020-09-30	$292,370	20,604	—	Shares	Defined	2020-12-11
No filing history on record for this holder in this stock.